{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:36:45Z","timestamp":1751481405843},"reference-count":29,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1507\/endocrj.ej17-0543","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T22:18:48Z","timestamp":1519251528000},"page":"469-477","source":"Crossref","is-referenced-by-count":20,"title":["Berberine inhibits glucose oxidation and insulin secretion in rat islets"],"prefix":"10.1507","volume":"65","author":[{"given":"Mengyao","family":"Bai","sequence":"first","affiliation":[{"name":"Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiye","family":"Zhou","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shushu","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kecheng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2 Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, et al. (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355: 2427\u20132443.","DOI":"10.1056\/NEJMoa066224"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3 Alarcon C, Boland BB, Uchizono Y, Moore PC, Peterson B, et al. (2016) Pancreatic \u03b2-cell adaptive plasticity in obesity increases insulin production but adversely affects secretory function. Diabetes 65: 438\u2013450.","DOI":"10.2337\/db15-0792"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4 Xing LJ, Zhang L, Liu T, Hua YQ, Zheng PY, et al. (2011) Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver. Eur J Pharmacol 668: 467\u2013471.","DOI":"10.1016\/j.ejphar.2011.07.036"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5 Chen C, Tao C, Liu Z, Lu M, Pan Q, et al. (2015) A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome. Phytother Res 29: 1822\u20131827.","DOI":"10.1002\/ptr.5475"},{"key":"5","doi-asserted-by":"publisher","unstructured":"6 Yin J, Xing H, Ye J (2008) Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57: 712\u2013717.","DOI":"10.1016\/j.metabol.2008.01.013"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7 Zhang Y, Li X, Zou D, Liu W, Yang J, et al. (2008) Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 93: 2559\u20132565.","DOI":"10.1210\/jc.2007-2404"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8 Cheng Z, Pang T, Gu M, Gao AH, Xie CM, et al. (2006) Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. Biochim Biophys Acta 1760: 1682\u20131689.","DOI":"10.1016\/j.bbagen.2006.09.007"},{"key":"8","doi-asserted-by":"publisher","unstructured":"9 Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, et al. (2006) Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55: 2256\u20132264.","DOI":"10.2337\/db06-0006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10 Zhou L, Wang X, Shao L, Yang Y, Shang W, et al. (2008) Berberine acutely inhibits insulin secretion from \u03b2-cells through 3&apos;,5&apos;-cyclic adenosine 5&apos;-monophosphate signaling pathway. Endocrinology 149: 4510\u20134518.","DOI":"10.1210\/en.2007-1752"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11 Komatsu M, Takei M, Ishii H, Sato Y (2013) Glucose-stimulated insulin secretion: a newer perspective. J Diabetes Investig 4: 511\u2013516.","DOI":"10.1111\/jdi.12094"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12 Mugabo Y, Zhao S, Lamontagne J, Al-Mass A, Peyot ML, et al. (2017) Metabolic fate of glucose and candidate signaling and excess-fuel detoxification pathways in pancreatic \u03b2-cells. J Biol Chem 292: 7407\u20137422.","DOI":"10.1074\/jbc.M116.763060"},{"key":"12","doi-asserted-by":"publisher","unstructured":"13 Sato Y, Aizawa T, Komatsu M, Okada N, Yamada T (1992) Dual functional role of membrane depolarization\/Ca 2+ influx in rat pancreatic B-cell. Diabetes 41: 438\u2013443.","DOI":"10.2337\/diabetes.41.4.438"},{"key":"13","unstructured":"14 Newgard CB, Lu D, Jensen MV, Schissler J, Boucher A, et al. (2002) Stimulus\/secretion coupling factors in insights gained from a multidisciplinary approach. Diabetes 51 suppl 3: S389\u2013S393."},{"key":"14","doi-asserted-by":"crossref","unstructured":"15 Lamontagne J, Al-Mass A, Nolan CJ, Corkey BE, Madiraju SRM, et al. (2017) Identification of the signals for glucose-induced insulin secretion in INS1 (832\/13) \u03b2-cells using metformin-induced metabolic deceleration as a model. J Biol Chem 292: 19458\u201319468.","DOI":"10.1074\/jbc.M117.808105"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16 Deng R, Nie A, Jian F, Liu Y, Tang H, et al. (2014) Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion <i>via<\/i> activating AMPK. Biochim Biophys Acta 1840: 577\u2013585.","DOI":"10.1016\/j.bbagen.2013.10.021"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17 da Silva Xavier G, Leclerc I, Varadi A, Tsuboi T, Moule SK, et al. (2003) Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochem J 371: 761\u2013774.","DOI":"10.1042\/bj20021812"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18 Dentin R, Denechaud PD, Benhamed F, Girard J, Postic C (2006) Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP. J Nutr 136: 1145\u20131149.","DOI":"10.1093\/jn\/136.5.1145"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Prentki M, Madiraju SR (2012) Glycerolipid\/free fatty acid cycle and islet \u03b2-cell function in health, obesity and diabetes. Mol Cell Endocrinol 353: 88\u2013100.","DOI":"10.1016\/j.mce.2011.11.004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20 Zhang Z, Zhang H, Li B, Meng X, Wang J, et al. (2014) Berberine activates thermogenesis in white and brown adipose tissue. Nat Commun 5: 5493.","DOI":"10.1038\/ncomms6493"},{"key":"20","doi-asserted-by":"publisher","unstructured":"21 Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, et al. (2003) Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422: 173\u2013176.","DOI":"10.1038\/nature01478"},{"key":"21","doi-asserted-by":"publisher","unstructured":"22 Turner N, Li JY, Gosby A, To SW, Cheng Z, et al. (2008) Berberine and its more biologically available derivative dihyroberberine, inhibit mitochondrial respiration. Diabetes 57: 1414\u20131418.","DOI":"10.2337\/db07-1552"},{"key":"22","unstructured":"23 Xu M, Xiao Y, Yin J, Hou W, Yu X, et al. (2014) Berberine promotes glucose consumption independently of AMP-activated protein kinase activation. PLoS One 9: e103702."},{"key":"23","doi-asserted-by":"crossref","unstructured":"24 Mahmood S, Birkaya B, Rideout TC, Patel MS (2016) Lack of mitochondria-generated acetyl-CoA by pyruvate dehydrogenase complex downregulates gene expression in the hepatic <i>de novo<\/i> lipogenic pathway. Am J Physiol Endocrinol Metab 311: E117\u2013E127.","DOI":"10.1152\/ajpendo.00064.2016"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25 Jensen MV, Joseph JW, Ronnebaum SM, Burgess SC, Sherry AD, et al. (2008) Metabolic cycling in control of glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 295: E1287\u2013E1297.","DOI":"10.1152\/ajpendo.90604.2008"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26 Zhang J, Tang H, Deng R, Wang N, Zhang Y, et al. (2015) Berberine suppresses adipocyte differentiation <i>via<\/i> decreasing CREB transcriptional activity. PLoS One 10: e0125667.","DOI":"10.1371\/journal.pone.0125667"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27 Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, et al. (2005) Calmodulin-dependent protein kinase kinase-\u03b2 is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2: 9\u201319.","DOI":"10.1016\/j.cmet.2005.05.009"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28 Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, et al. (2003) AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31: 162\u2013168.","DOI":"10.1042\/bst0310162"},{"key":"28","doi-asserted-by":"publisher","unstructured":"29 Herzig S, Shaw RJ (2017) AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol doi: 10.1038\/nrm.2017.95. [Epub ahead of print]","DOI":"10.1038\/nrm.2017.95"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30 Hawley SA, Davison M, Woods A, Davies SP, Beri RK, et al. (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271: 27879\u201327887.","DOI":"10.1074\/jbc.271.44.27879"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/4\/65_EJ17-0543\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T10:05:02Z","timestamp":1570788302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/4\/65_EJ17-0543\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej17-0543","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}